Phase 4 Depression and Anxiety Trial, Recruiting NCT07182890 Sponsor: Xijing Hospital of Digestive Diseases Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 4 Depression and Anxiety Trial, Recruiting

NCT07182890
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a condition called functional dyspepsia (a type of ongoing stomach discomfort or indigestion with no clear physical cause), based on a standard set of medical guidelines called the Rome IV criteria
  • People aged between 18 and 80 years old, of any gender
  • People whose score on a standard questionnaire measuring anxiety and depression (called the HADS scale) falls between 8 and 14, indicating mild to moderate symptoms

Who may not be able to join:

  • People who have taken probiotics or antibiotics in the month before the trial
  • People who have taken medications that affect mood or mental state — such as sleeping pills, sedatives, anti-anxiety medications, or antidepressants — in the month before the trial
  • People who have used hormones, immune-suppressing medications, or certain cancer-related drugs in the month before the trial
  • People who have taken part in another clinical trial within the month before this study
  • People who test positive for a stomach bacteria called Helicobacter pylori
  • People who regularly take traditional Chinese herbal medicines
  • People who are pregnant or breastfeeding
  • People with a history of drug abuse
  • People who have other significant health conditions that could interfere with the trial, such as irritable bowel syndrome, acid reflux disease, functional constipation, serious liver or kidney problems, breathing disorders, autoimmune conditions, bleeding disorders, psychiatric conditions, or hormonal disorders (confirm with trial site for the full list)
  • People who have had major surgery or have been diagnosed with diabetes
  • People who are unwilling to sign a written consent form agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 029-84771515

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Xijing Hospital of Digestive Diseases
Registry
ClinicalTrials.gov
Start date
20 September 2025
Est. completion
30 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Hospital Anxiety and Depression Scale (HADS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov